MIGHT REDUCTION OF PLASMA-CHOLESTEROL IMPERIL CELL PHYSIOLOGY

被引:4
作者
OLIVER, MF
机构
关键词
D O I
10.1016/0022-2828(91)90090-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1335 / 1337
页数:3
相关论文
共 10 条
[1]  
[Anonymous], 1984, LANCET, V2, P600
[2]   HELSINKI HEART-STUDY - PRIMARY-PREVENTION TRIAL WITH GEMFIBROZIL IN MIDDLE-AGED MEN WITH DYSLIPIDEMIA - SAFETY OF TREATMENT, CHANGES IN RISK-FACTORS, AND INCIDENCE OF CORONARY HEART-DISEASE [J].
FRICK, MH ;
ELO, O ;
HAAPA, K ;
HEINONEN, OP ;
HEINSALMI, P ;
HELO, P ;
HUTTUNEN, JK ;
KAITANIEMI, P ;
KOSKINEN, P ;
MANNINEN, V ;
MAENPAA, H ;
MALKONEN, M ;
MANTTARI, M ;
NOROLA, S ;
PASTERNACK, A ;
PIKKARAINEN, J ;
ROMO, M ;
SJOBLOM, T ;
NIKKILA, EA .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (20) :1237-1245
[3]   LOWERING CHOLESTEROL CONCENTRATIONS AND MORTALITY - A QUANTITATIVE REVIEW OF PRIMARY PREVENTION TRIALS [J].
MULDOON, MF ;
MANUCK, SB ;
MATTHEWS, KA .
BMJ-BRITISH MEDICAL JOURNAL, 1990, 301 (6747) :309-314
[4]   REDUCING CHOLESTEROL DOES NOT REDUCE MORTALITY [J].
OLIVER, MF .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1988, 12 (03) :814-817
[5]  
VIRKKUNEN M, 1984, BIOL PSYCHIAT, V19, P435
[6]  
YUSUF S, 1987, SINGLE FACTOR TRIALS, P393
[7]  
1981, LANCET, V2, P1090
[8]  
1985, JAMA-J AM MED ASSOC, V251, P351
[9]  
1980, LANCET, V2, P379
[10]  
1970, BRIT HEART J, V40, P1069